These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6292251)

  • 1. Quantification of an Epstein-Barr virus-associated membrane antigen component.
    North JR; Morgan AJ; Thompson JL; Epstein MA
    J Virol Methods; 1982 Sep; 5(1):55-65. PubMed ID: 6292251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and properties of the gp340 component of Epstein-Barr virus membrane antigen in an immunogenic form.
    Morgan AJ; North JR; Epstein MA
    J Gen Virol; 1983 Feb; 64 (Pt 2)():455-60. PubMed ID: 6300296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA).
    Qualtiere LF; Pearson GR
    Virology; 1980 Apr; 102(2):360-9. PubMed ID: 6245514
    [No Abstract]   [Full Text] [Related]  

  • 4. Polypeptides of the Epstein-Barr virus membrane antigen complex.
    Thorley-Lawson DA; Edson CM
    J Virol; 1979 Nov; 32(2):458-67. PubMed ID: 228070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides.
    North JR; Morgan AJ; Epstein MA
    Int J Cancer; 1980 Aug; 26(2):231-40. PubMed ID: 6162806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale purification of Epstein-Barr virus membrane antigen gp340 with a monoclonal antibody immunoabsorbent.
    Randle BJ; Morgan AJ; Stripp SA; Epstein MA
    J Immunol Methods; 1985 Feb; 77(1):25-36. PubMed ID: 2579161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants.
    Dölken G; Klein G
    J Natl Cancer Inst; 1977 May; 58(5):1239-45. PubMed ID: 192896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins.
    Strnad BC; Neubauer RH; Rabin H; Mazur RA
    J Virol; 1979 Dec; 32(3):885-94. PubMed ID: 92577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.
    Franklin SM; North JR; Morgan AJ; Epstein MA
    J Gen Virol; 1981 Apr; 53(Pt 2):371-6. PubMed ID: 6167667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells.
    Thorley-Lawson DA
    Cell; 1979 Jan; 16(1):33-42. PubMed ID: 217544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient purification of Epstein-Barr virus membrane antigen gp340 by fast protein liquid chromatography.
    David EM; Morgan AJ
    J Immunol Methods; 1988 Apr; 108(1-2):231-6. PubMed ID: 2832478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity of Epstein-Barr virus early polypeptides induced by various tumor promoters.
    Kawanishi M; Ito Y
    Cancer Lett; 1982; 16(1):19-23. PubMed ID: 6288232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.
    Edson CM; Thorley-Lawson DA
    J Virol; 1981 Jul; 39(1):172-84. PubMed ID: 6268807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
    Qualtiere LF; Pearson GR
    Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular synthesis of Epstein-Barr virus membrane antigen gp350/220. Inhibitory effect of monensin on its expression.
    Bertoni G; Nguyen QV; Humphreys RE; Sairenji T
    Intervirology; 1989; 30(2):61-73. PubMed ID: 2542183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structural investigation of the Epstein-Barr (EB) virus membrane antigen glycoprotein, gp340.
    Morgan AJ; Smith AR; Barker RN; Epstein MA
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():397-404. PubMed ID: 6319581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Epstein-Barr virus membrane antigen gp340/220 in mouse fibroblasts using a bovine papillomavirus vector.
    Conway M; Morgan A; Mackett M
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():729-34. PubMed ID: 2543757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
    Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG
    Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B.
    Lees JF; Arrand JE; Pepper SD; Stewart JP; Mackett M; Arrand JR
    Virology; 1993 Aug; 195(2):578-86. PubMed ID: 8393237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
    Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.